Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Biochemical Genetics|April 21, 2025
Genomic Insights into Oral Cancer Highlight Mutant SIGMAR1 as a Critical Target to Overcome ChemoresistancePablo Shimaoka Chagas, Cristiana Bernadelli Garcia, Andréia Machado LeopoldinoKidney360|July 6, 2026
Kidney Health in a Changing Climate: Emerging Disease Patterns and Driving MechanismsSuemy Melim Yamada, Marcella Cipelli, Pablo Shimaoka Chagas, et al.Epigenomics|December 22, 2023
SET protein as an epigenetics targetGabriel da Silva, Thaís Moré Milan, Pablo Shimaoka Chagas, et al.Molecular Biology Reports|February 11, 2025
Suppression of SIGMAR1 hinders oral cancer cell growth via modulation of mitochondrial Ca<sup>2+</sup> dynamicsPablo Shimaoka Chagas, Cristiana Bernadelli Garcia, Henrique Izumi Shimaoka Chagas, et al.Journal of Cellular Biochemistry|June 26, 2024
Network-Based Transcriptome Analysis Reveals FAM3C as a Novel Potential Biomarker for GlioblastomaPablo Shimaoka Chagas, Henrique Izumi Shimaoka Chagas, Sahar Emami Naeini, et al.International Journal of Molecular Sciences|November 27, 2024
<i>SIGMAR1</i> Knockdown Enhances Oral Cancer Cell Chemosensitivity to Cisplatin via Decreased <i>PD-L1</i> ExpressionPablo Shimaoka Chagas, Cristiana Bernadelli Garcia, Lucas Oliveira Sousa, et al.Archives of Dermatological Research|May 22, 2024
Reprofiling synthetic glucocorticoid-induced leucine zipper fusion peptide as a novel and effective hair growth promoterSahar Emami Naeini, Bidhan Bhandari, Jules Gouron, et al.Medical Oncology (Northwood, London, England)|June 29, 2026
Novel patient-derived tongue squamous cell carcinoma cell lines from non-smokers: 3D and in vivo models for drug response studiesGraziella Ribeiro de Sousa, Guilherme da Silva Carvalho, Bruna Miyoko Ikenaga de Brito, et al.Medical Oncology (Northwood, London, England)|May 7, 2024
Altering biomolecular condensates as a potential mechanism that mediates cannabidiol effect on glioblastomaLei P Wang, Pablo Shimaoka Chagas, Évila Lopes Salles, et al.Cerebellum (London, England)|July 9, 2026
Therapeutic Potential of Targeting USP2 in Pediatric Group 3 and 4 Medulloblastomas: Insights from In Silico, Ex Vivo, and In Vitro StudiesJonas José da Silva, Manuela Eduarda de França, Alcides Euzebio Tavares Xavier, et al.Pageof 2